"Antigens, CD" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
Descriptor ID |
D015703
|
MeSH Number(s) |
D23.050.301.264.035 D23.101.100.110
|
Concept/Terms |
Antigens, CD- Antigens, CD
- CD Antigens
- Cluster of Differentiation Markers
- Cluster of Differentiation Antigens
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD".
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD".
This graph shows the total number of publications written about "Antigens, CD" by people in this website by year, and whether "Antigens, CD" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 15 | 12 | 27 |
1995 | 4 | 15 | 19 |
1996 | 11 | 15 | 26 |
1997 | 13 | 9 | 22 |
1998 | 11 | 14 | 25 |
1999 | 10 | 17 | 27 |
2000 | 12 | 18 | 30 |
2001 | 12 | 11 | 23 |
2002 | 15 | 26 | 41 |
2003 | 9 | 22 | 31 |
2004 | 16 | 29 | 45 |
2005 | 10 | 36 | 46 |
2006 | 6 | 35 | 41 |
2007 | 18 | 25 | 43 |
2008 | 24 | 15 | 39 |
2009 | 13 | 21 | 34 |
2010 | 18 | 12 | 30 |
2011 | 11 | 19 | 30 |
2012 | 10 | 19 | 29 |
2013 | 11 | 19 | 30 |
2014 | 7 | 16 | 23 |
2015 | 8 | 12 | 20 |
2016 | 6 | 15 | 21 |
2017 | 6 | 8 | 14 |
2018 | 6 | 9 | 15 |
2019 | 8 | 10 | 18 |
2020 | 9 | 8 | 17 |
2021 | 2 | 6 | 8 |
2022 | 2 | 3 | 5 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, CD" by people in Profiles.
-
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.
-
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin. Cell Rep. 2023 10 31; 42(10):113254.
-
Analytical validation of urine ALCAM ELISA as a test for lupus nephritis. Expert Rev Mol Diagn. 2023 Jul-Dec; 23(8):729-738.
-
Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis. Rheumatology (Oxford). 2023 03 01; 62(3):1335-1342.
-
Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. J Med Genet. 2023 06; 60(6):568-575.
-
Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy. Clin Cancer Res. 2022 12 01; 28(23):5030-5039.
-
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma. Mol Cancer. 2022 09 26; 21(1):185.
-
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer. J Nanobiotechnology. 2022 Sep 19; 20(1):417.
-
Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus. Front Immunol. 2022; 13:885307.
-
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. N Engl J Med. 2022 01 06; 386(1):24-34.